Real-time enrollment status for this alzheimer's disease clinical trial
Current Status
Recruiting
Checked: October 14, 2026 at 4:59 AM UTC
| NCT Number | NCT07717411 |
| Recruiting Status | Recruiting |
| Condition | Alzheimer's Disease |
| Phase | PHASE3 |
| Target Enrollment | 1,600 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Hoffmann-La Roche |
| Last Updated on CT.gov | October 13, 2026 (Yesterday) |
As of October 14, 2026: Clinical trial NCT07717411 is currently recruiting participants. This phase3 study for alzheimer's disease is actively seeking new participants at 12 locations across the United States. The study is sponsored by Hoffmann-La Roche. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07717411 is actively recruiting participants as of October 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07717411 was last updated Yesterday (October 13, 2026). HelloStudys verifies this status automatically.